Crinetics Pharmaceuticals (NasdaqGS:CRNX) FDA Announcement September 25, 2025 06:00 PM ET Company ParticipantsGayathri Diwakar - Senior Director - IRR. Scott Struthers - President, Co-Founder, CEO & DirectorDana Pizzuti - Chief Medical & Development OfficerIsabel Kalofonos - Chief Commercial OfficerJosh Schimmer - Managing DirectorTobin Schilke - CFOGavin Clark-Gartner - MD - Biotechnology Equity ResearchJoseph Schwartz - Senior MD - Rare DiseasesSelena Zhang - Global capital marketsAlan Krasner - Chief End ...